올리고뉴클레오티드 칩(Oligonucleotide Chip)을 이용한 항결핵제 감수성과 관련된 Mycobacterium tuberculosis rpoB 유전자의 점돌연변이 판별 방법 Detection of Point Mutations in the rpoB Gene Related to Drug Susceptibility in Mycobacterium Tuberculosis using an Oligonucleotide Chip원문보기
결핵환자에 있어 rpoB 유전자 염기서열 돌연변이로 인해 생겨나는 rifampin(RIF)내성은 화학요법치료에서 나타나는 다제내성의 표지자로서 많은 연구가 되어 있으며 rifabutin(RIB)은 이러한 RIF의 내성을 보이는 일부 점돌연변이에 대하여 감성 또는 내성을 보이는 것으로 보고되고 있다. 그러므로 본 연구에서는 mycobacteria rpoB 유전자의 특정 DNA 서열(17 bp)을 고정한 올리고뉴클레오티드 칩을 개발하여 rpoB 유전자의 점돌연변이으로 인한 RIF과 RIB의 감수성을 조사하고자 하였다. 방법 : 사용된 올리고뉴클레오티드 칩은 RIF 내성 프로브 및 RIB 감성 프로브를 포함하도록 고안되었으며, 각각의 돌연변이에 상응하는 야생형 프로브를 동일한 염기서열에서 선정하여 형광 시그날 세기의 직접비교에 의해 보다 정확한 탐지를 가능하게 하였다. 결과 : 15개의 임상 분리체를 검사한 결과 RIF 내성으로 밝혀진 돌연변이중 13개의 임상 분리체에서 RIB 감수성 돌연변이 종류를 판별할 수 있었다. 결론 : 올리고뉴레오티드 칩으로 rpoB 유전자에 대한 점돌연변이 연구는 결핵환자에 대한 RIF과 RIB 약제내성 유무를 판단케 함으로써 효과적인 화학요법치료를 가능케 할 것이며 기존 방법과 비교시 효율 및 재현성이 매우 높다고 판단되었다.
결핵환자에 있어 rpoB 유전자 염기서열 돌연변이로 인해 생겨나는 rifampin(RIF)내성은 화학요법치료에서 나타나는 다제내성의 표지자로서 많은 연구가 되어 있으며 rifabutin(RIB)은 이러한 RIF의 내성을 보이는 일부 점돌연변이에 대하여 감성 또는 내성을 보이는 것으로 보고되고 있다. 그러므로 본 연구에서는 mycobacteria rpoB 유전자의 특정 DNA 서열(17 bp)을 고정한 올리고뉴클레오티드 칩을 개발하여 rpoB 유전자의 점돌연변이으로 인한 RIF과 RIB의 감수성을 조사하고자 하였다. 방법 : 사용된 올리고뉴클레오티드 칩은 RIF 내성 프로브 및 RIB 감성 프로브를 포함하도록 고안되었으며, 각각의 돌연변이에 상응하는 야생형 프로브를 동일한 염기서열에서 선정하여 형광 시그날 세기의 직접비교에 의해 보다 정확한 탐지를 가능하게 하였다. 결과 : 15개의 임상 분리체를 검사한 결과 RIF 내성으로 밝혀진 돌연변이중 13개의 임상 분리체에서 RIB 감수성 돌연변이 종류를 판별할 수 있었다. 결론 : 올리고뉴레오티드 칩으로 rpoB 유전자에 대한 점돌연변이 연구는 결핵환자에 대한 RIF과 RIB 약제내성 유무를 판단케 함으로써 효과적인 화학요법치료를 가능케 할 것이며 기존 방법과 비교시 효율 및 재현성이 매우 높다고 판단되었다.
Background : The appearance of multiple-drug-resistant Mycobacterium tuberculosis strains has been seriously compromising successful control of tuberculosis. Rifampin-resistance, caused by mutations in the rpoB gene, can be indicative of multiple-drug-resistance, and its detection is of great import...
Background : The appearance of multiple-drug-resistant Mycobacterium tuberculosis strains has been seriously compromising successful control of tuberculosis. Rifampin-resistance, caused by mutations in the rpoB gene, can be indicative of multiple-drug-resistance, and its detection is of great importance. The present study aimed to develop an oligonucleotide chip for accurate and convenient screening of drug-resistance. Methods : In order to detect point mutations in the rpoB gene, an oligonucleotide chip was prepared by immobilizing specific probe DNA to a microscopic slide glass by a chemical reaction. The probe DNA that was selected from the 81 bp core region of the rpoB gene was designed to have mutation sites at the center. A total of 17 mutant probes related to rifampin-resistance including 8 rifabutin-sensitive mutant probes were used in this study. For accurate determination, wild type probes were prepared for each mutation position with an equal length, which enabled a direct comparison of the hybridization intensities between the mutant and wild type. Results : Mycobacterial genomic DNA from clinical samples was tested with the oligonucleotide chip and the results were compared with those of the drug-susceptibility test in addition to sequencing and INNO-LiPA Rif. TB kit test in some cases. Out of 15 samples, the oligonucleotide chip results of 13 samples showed good agreement with the rifabutin-sensitivity results. The two samples with conflicting result also showed a discrepancy between the other tests, suggesting such possibilities as existence of mixed strains and difference in drug-sensitivity. Further verification of these samples in addition to more case studies are required before the final evaluation of the oligonucleotide chip can be made. Conlcusion : An oligonucleotide chip was developed for the detection of rpoB gene mutations related to drugsusceptibility. The results to date show the potential for using the oligonucleotide chip for accurate and convenient screening of drug-resistance to provide useful information in antituberculosis drug therapy.
Background : The appearance of multiple-drug-resistant Mycobacterium tuberculosis strains has been seriously compromising successful control of tuberculosis. Rifampin-resistance, caused by mutations in the rpoB gene, can be indicative of multiple-drug-resistance, and its detection is of great importance. The present study aimed to develop an oligonucleotide chip for accurate and convenient screening of drug-resistance. Methods : In order to detect point mutations in the rpoB gene, an oligonucleotide chip was prepared by immobilizing specific probe DNA to a microscopic slide glass by a chemical reaction. The probe DNA that was selected from the 81 bp core region of the rpoB gene was designed to have mutation sites at the center. A total of 17 mutant probes related to rifampin-resistance including 8 rifabutin-sensitive mutant probes were used in this study. For accurate determination, wild type probes were prepared for each mutation position with an equal length, which enabled a direct comparison of the hybridization intensities between the mutant and wild type. Results : Mycobacterial genomic DNA from clinical samples was tested with the oligonucleotide chip and the results were compared with those of the drug-susceptibility test in addition to sequencing and INNO-LiPA Rif. TB kit test in some cases. Out of 15 samples, the oligonucleotide chip results of 13 samples showed good agreement with the rifabutin-sensitivity results. The two samples with conflicting result also showed a discrepancy between the other tests, suggesting such possibilities as existence of mixed strains and difference in drug-sensitivity. Further verification of these samples in addition to more case studies are required before the final evaluation of the oligonucleotide chip can be made. Conlcusion : An oligonucleotide chip was developed for the detection of rpoB gene mutations related to drugsusceptibility. The results to date show the potential for using the oligonucleotide chip for accurate and convenient screening of drug-resistance to provide useful information in antituberculosis drug therapy.
AI-Helper
※ AI-Helper는 부적절한 답변을 할 수 있습니다.